The dog days are over
The dog days are over
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
9 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bitcoin stalls after hotter-than-expected inflation reading
Bitcoin and other major cryptocurrencies softened after the Federal Reserve’s preferred inflation gauge came in hotter than expected, while Ethereum rose.
Bitcoin, Ethereum rise as XRP and Dogecoin slide
Bitcoin rose 0.11% to $77,357.55 and Ethereum gained 0.97% to $2,450.00, while XRP fell 0.78% and Dogecoin dropped 1.90% amid a broader crypto pullback.
Bitcoin, Ethereum, XRP, Dogecoin stay range-bound amid low volume
Bitcoin trades sideways as July CPI and PPI match expectations, while Coinglass reports 74,736 traders liquidated for $232.50 million and SoSoValue shows net outflows of $61.2 million from spot Bitcoin ETFs.
Bitcoin Dips, Ethereum, XRP Rise
Bitcoin dips 0.44% to $63,704.13, while Ethereum, XRP, and Dogecoin rise
Weak Investor Sentiment Overshadows Energy Drink Maker's Strong Growth
Weak investor sentiment has dogged Eastroc since its Hong Kong IPO in February, even as the energy drink maker reports strong growth image credit: Bamboo Works Key Takeaways: Eastroc lost over $1 billion in market cap over five days as its Shanghai- and Hong Kong-listed stocks tanked after the release of an AI-generate
Tesla Stock Falls After 'Monster Delivery Number,' Gene Munster Knows The Reasons Why
Tesla Inc (NASDAQ: TSLA ) shares fell Thursday despite topping estimates for second-quarter deliveries, and Deepwater Asset Management’s Gene Munster explained why. The electric vehicle (EV) maker reported second-quarter deliveries of 480,126 vehicles, up 25% year-over-year and up 34% from the first quarter. This total
Tri Pointe CEO
Tri Pointe Homes CEO Doug Bauer says the newly approved bipartisan housing bill is unlikely to solve America's affordability crisis, citing state and local level barriers as the main issue
RGNX: FDA Reconsiders Gene Therapy
Regenxbio aligns with FDA on next steps for potential accelerated approval of Navsunli gene therapy